We are live on ! Find out more
Morgan Stanley

Morgan Stanley Portfolio holdings

AUM $1.66T
1-Year Est. Return 25.57%
 

Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.

This Fund
S&P 500
This Quarter Est. Return
+28.45%
1 Year Est. Return
+25.57%
3 Year Est. Return
+85.95%
5 Year Est. Return
+96.01%
10 Year Est. Return
+409.32%
AUM
$452B
AUM Growth
+$83.8B
Cap. Flow
-$1.84B
Cap. Flow %
-0.41%
Top 10 Hldgs %
16.9%
Holding
6,941
New
185
Increased
3,288
Reduced
2,645
Closed
222

Sector Composition

Rank Sector Weight
1 Technology 19.32%
2 Healthcare 10.4%
3 Consumer Discretionary 8.1%
4 Communication Services 7.82%
5 Financials 7.44%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ARL icon
6101
American Realty Investors
ARL
$254M
$5K ﹤0.01%
559
+125
+29% +$1.01K
BIS icon
6102
ProShares UltraShort NASDAQ Biotechnology
BIS
$2.34M
$5K ﹤0.01%
80
-880
-92% -$68.5K
CARM
6103
DELISTED
Carisma Therapeutics
CARM
$5K ﹤0.01%
366
+123
+51% +$1.66K
CLSK icon
6104
CleanSpark
CLSK
$3.53B
$5K ﹤0.01%
1,850
+1,800
+3,600% +$3.4K
COGT icon
6105
Cogent Biosciences
COGT
$6.72B
$5K ﹤0.01%
2,856
-1,863
-39% -$3.46K
DGICB
6106
Donegal Group Class B
DGICB
$5K ﹤0.01%
429
HYMC icon
6107
Hycroft Mining Holding Corp
HYMC
$1.78B
$5K ﹤0.01%
+50
New +$5.06K
JVAL icon
6108
JPMorgan US Value Factor ETF
JVAL
$832M
$5K ﹤0.01%
+215
New +$4.94K
MYSZ icon
6109
My Size
MYSZ
$1.84M
$5K ﹤0.01%
23
NCSM icon
6110
NCS Multistage Holdings
NCSM
$120M
$5K ﹤0.01%
447
+128
+40% +$1.47K
OILK icon
6111
ProShares K-1 Free Crude Oil Strategy ETF
OILK
$207M
$5K ﹤0.01%
+150
New +$5.04K
OMFL icon
6112
Invesco Russell 1000 Dynamic Multifactor ETF
OMFL
$4.73B
$5K ﹤0.01%
160
+78
+95% +$2.31K
PBUS icon
6113
Invesco MSCI USA ETF
PBUS
$11.3B
$5K ﹤0.01%
+149
New +$4.37K
SANW
6114
DELISTED
S&W Seed Co
SANW
$5K ﹤0.01%
122
+1
+0.8% +$39
TGLS icon
6115
Tecnoglass
TGLS
$1.95B
$5K ﹤0.01%
838
-120
-13% -$503
TTT icon
6116
ProShares UltraPro Short 20+ Year Treasury
TTT
$19.5M
$5K ﹤0.01%
172
-1
-0.6% -$29
TUSK icon
6117
Mammoth Energy Services
TUSK
$127M
$5K ﹤0.01%
4,447
+3,132
+238% +$3.63K
UTSI icon
6118
UTStarcom
UTSI
$23.5M
$5K ﹤0.01%
750
VEGN icon
6119
US Vegan Climate ETF
VEGN
$181M
$5K ﹤0.01%
175
-700
-80% -$17.9K
ACCS
6120
ACCESS Newswire
ACCS
$25.9M
$5K ﹤0.01%
502
VIRX
6121
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
$5K ﹤0.01%
608
+450
+285% +$6.78K
KA
6122
DELISTED
Kineta, Inc. Common Stock
KA
$5K ﹤0.01%
29
SBOW
6123
DELISTED
SilverBow Resources, Inc.
SBOW
$5K ﹤0.01%
1,388
-229
-14% -$925
BPTH
6124
DELISTED
Bio-Path Holdings Inc
BPTH
$5K ﹤0.01%
51
-38
-43% -$3.94K
GFED
6125
DELISTED
Guaranty Federal Bancshares In
GFED
$5K ﹤0.01%
345

Similar funds

Morgan Stanley's Q2 2020 Portfolio in Review

As of Q2 2020, Morgan Stanley held 6,941 positions worth $452B, up 23% from $368B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Morgan Stanley's Q2 2020 filing shows 185 new, 3,288 increased, 2,645 reduced and 222 closed positions. Its largest new stake was Royalty Pharma: 6,205,186 shares worth $301M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $5.07B.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 16% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Morgan Stanley's largest Q2 2020 buy was Royalty Pharma: 6,205,186 shares worth $301M.
  • Morgan Stanley added most to Block Inc in Q2 2020, an estimated $1.53B increase.
  • Morgan Stanley's biggest Q2 2020 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $5.07B.
  • Morgan Stanley fully exited Allergan plc in Q2 2020, selling an estimated $487M.
  • Morgan Stanley's ten largest holdings make up 17% of its $452B portfolio in Q2 2020.
  • Morgan Stanley opened 185 new positions and closed 222 in Q2 2020.
  • Morgan Stanley's portfolio value rose 23% quarter-over-quarter to $452B.

Based on Morgan Stanley's 13F filing for Q2 2020, filed 14 Aug 2020.